Publication | Open Access

Osteoanabolic effect of alendronate and zoledronate on bone marrow stromal cells (BMSCs) isolated from aged female osteoporotic patients and its implications for their mode of action in the treatment of age-related bone loss

Bone DiseaseBone HealthAge-related Bone LossOrthopaedic SurgeryFemale Osteoporotic PatientsPharmacologyOsteoarthritisOsteoanabolic EffectMedicineOsteoporosisBone Metabolism